LHC: NEPS expected to rise 6%–10% and revenue up 2.2%–2.6% despite operational headwinds

Normalised EBITDA margin and NEPS are expected to improve 6%–10% year-over-year, with revenue up 2.2%–2.6% despite a challenging environment and a major funder under curatorship. Acute hospital PPDs declined, but complementary businesses grew 3.4%.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.